Clinical Trial

Prospective Cohort Study of Neuromyelitis Optica Spectrum Disorders (NMOSD)

Study acronym: NMOSD
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to characterize sex hormone alterations and their potential clinical significance in NMOSD patients from Southern China through comprehensive hormonal profiling.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-03.
Trial Details
NCT Number NCT07266051
Lead Sponsor Xiamen Hospital of Traditional Chinese Medicine
Conditions NMOSD
Enrollment 4,000 participants
Start Date 2025-12
Primary Completion 2030-07 (estimated)
Study Completion 2030-12 (estimated)
Updated on ClinicalTrials.gov 2025-12-18